Trial Profile
Calblock tablet postmarketing clinical study (Essential hypertensive patients with type 2 diabetes)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2016
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Temocapril (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 14 Jun 2016 New trial record